Abanid, Viola B.

HRN: 01-45-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/13/2025
04/20/2025
IV
300mg
Q6h
T/c Acute Tonsillopharyngitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: